Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Arvaya HealthcareBOM:524723 36 Days Payable is 233.68 as of Mar. 2026, which is 415% above its 10-year median of 45.36. GuruFocus rates BOM:524723 with a GF Score™ of 36/100 and a GF Value™ of ₹49.46 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 115 Medical Distribution companies, Arvaya Healthcare ranks better than 98.26% on this metric.
The historical rank and industry rank for Arvaya Healthcare's Days Payable or its related term are showing as below:
BOM:524723'
s Days Payable Range Over the Past 10 Years
Min: 8.59 Med: 45.36 Max: 934.7
Current: 934.7
During the past 13 years, Arvaya Healthcare's highest Days Payable was 934.70. The lowest was 8.59. And the median was 45.36.
BOM:524723's Days Payable is ranked better than 98.26% of 115
companies
in the Medical Distribution industry
Industry Median: 79.11
vs BOM:524723: 934.70
Arvaya Healthcare's Days Payable
increased
from Mar. 2025 (0.00) to Mar. 2026 (233.68).
It may suggest that Arvaya Healthcaredelayed paying its suppliers.
Arvaya Healthcare Days Payable Related Terms
Arvaya Healthcare Days Payable Historical Data
* Premium members only.
The historical data trend for Arvaya Healthcare's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524723 vs MCK, CAH, COR: Days Payable Comparison
For the Medical Distribution subindustry, Arvaya Healthcare's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arvaya Healthcare Days Payable vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Arvaya Healthcare's Days Payable distribution charts can be found below:
* The bar in red indicates where Arvaya Healthcare's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Arvaya Healthcare's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arvaya Healthcare (BOM:524723) has a Days Payable of 233.68 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Arvaya Healthcare and its competitors. This is 415% above median its historical median of 45.36. Over the past decade, Arvaya Healthcare's Days Payable has ranged from 8.59 to 934.70. According to the industry distribution chart, Arvaya Healthcare ranks #2 out of 115 companies in the Medical Distribution industry, placing it in the top 1.7%.
Is Arvaya Healthcare's Days Payable too high?
Arvaya Healthcare's current Days Payable of 233.68 is 415% above median its 10-year median of 45.36. Over the past 10 years, this metric has ranged from a low of 8.59 to a high of 934.70. The Medical Distribution industry median Days Payable is 79.11. Arvaya Healthcare's value of 233.68 is 195.4% above this industry median. Based on the distribution chart, Arvaya Healthcare ranks #2 out of 115 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Arvaya Healthcare has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Arvaya Healthcare's Days Payable compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Arvaya Healthcare ranks #2 out of 115 companies for Days Payable. This places Arvaya Healthcare in the top 2% of its industry — outperforming the majority of peers. The industry median Days Payable is 79.11. Arvaya Healthcare's value of 233.68 is 195.4% above this benchmark. Historically, Arvaya Healthcare's own Days Payable has ranged from 8.59 to 934.70 over the past decade. While the company's 10-year median is 45.36 vs. the industry median of 79.11, Arvaya Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Distribution company?
The median Days Payable among Medical Distribution companies is 79.11, based on 115 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arvaya Healthcare's current Days Payable of 233.68 is 195.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Arvaya Healthcare and its competitors. For the Medical Distribution industry, the median Days Payable is 79.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arvaya Healthcare's current Days Payable is 233.68, which is 415% above median its own 10-year median of 45.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arvaya Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Arvaya Healthcare (BOM:524723) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹49.46, compared to a current price of ₹104.05 — trading 110.4% above its estimated fair value. The current Days Payable is 233.68, which is 415% above median its 10-year median of 45.36 and 195.4% above the Medical Distribution industry median of 79.11. Arvaya Healthcare's overall GF Score™ is 36/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Arvaya Healthcare (BOM:524723), the current Days Payable is 233.68 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arvaya Healthcare (BOM:524723) Overvalued in 2026?
Based on GuruFocus' analysis, Arvaya Healthcare stock appears to be overvalued.
The current stock price of ₹104.05 is trading 110.4% above its estimated GF Value™ of ₹49.46.
GuruFocus considers Arvaya Healthcare to be Significantly Overvalued.
Key valuation signals for BOM:524723:
Days Payable: 233.68 (415% above median its 10-year median of 45.36)
GF Value™: ₹49.46 vs. price of ₹104.05 (110.4% above fair value)
Industry Position: 195.4% above the Medical Distribution median (#2 of 115)
No single metric tells the full story. See the BOM:524723 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arvaya Healthcare Ltd is focused on developing an integrated healthcare platform in India that combines hospital services, diagnostics, wellness services, and digital health management solutions. Its operations include multi-specialty hospitals, a digital health platform for appointment booking and health record management, diagnostic services including laboratory testing and home sample collection, and wellness facilities offering preventive and recovery-focused programs.
36GF Score
Get the complete analysis for BOM:524723
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524723 has been successfully added to your 
